RipudamanSHundalMDFACE
Endocrinology • Newark, DEDiabetes, Lipid Metabolism, Thyroid
Director, First State Endocrinology
Dr. Hundal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
774 Christiana Rd
Ste 109
Newark, DE 19713Phone+1 302-444-8156Fax+1 302-731-8158
Education & Training
Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1999
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1993 - 1996
Government Medical College AmritsarClass of 1989
Certifications & Licensure
DE State Medical License 2001 - 2027
CT State Medical License 1996 - 2001
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 223 citationsMetformin: new understandings, new uses.Ripudaman S Hundal, Silvio E. Inzucchi
Drugs. 2003-01-01 - 494 citationsMechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetesRipudaman S. Hundal, Kitt Falk Petersen, Adam B. Mayerson, Pritpal S. Randhawa, Silvio E. Inzucchi
The Journal of Clinical Investigation. 2002-05-15 - 517 citationsThe Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 DiabetesAdam B. Mayerson, Ripudaman S. Hundal, Sylvie Dufour, Vincent Lebon, Douglas E. Befroy
Diabetes. 2002-03-01
Press Mentions
Top Doctors 2018October 5th, 2018- Top Doctors 2017October 2nd, 2017
- Top Doctors 2016October 4th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
